161 related articles for article (PubMed ID: 32019810)
1. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
[TBL] [Abstract][Full Text] [Related]
2. 27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.
Galvan GC; Friedrich NA; Das S; Daniels JP; Pollan S; Dambal S; Suzuki R; Sanders SE; You S; Tanaka H; Lee YJ; Yuan W; de Bono JS; Vasilevskaya I; Knudsen KE; Freeman MR; Freedland SJ
Front Oncol; 2023; 13():1251297. PubMed ID: 38188290
[TBL] [Abstract][Full Text] [Related]
3. CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.
Alfaqih MA; Nelson ER; Liu W; Safi R; Jasper JS; Macias E; Geradts J; Thompson JW; Dubois LG; Freeman MR; Chang CY; Chi JT; McDonnell DP; Freedland SJ
Cancer Res; 2017 Apr; 77(7):1662-1673. PubMed ID: 28130224
[TBL] [Abstract][Full Text] [Related]
4. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
Gong A; He M; Krishna Vanaja D; Yin P; Karnes RJ; Young CY
Mol Nutr Food Res; 2009 Jul; 53(7):878-86. PubMed ID: 19437484
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol.
Wang X; Zhong F; Chen T; Wang H; Wang W; Jin H; Li C; Guo X; Liu Y; Zhang Y; Li B
Cell Mol Life Sci; 2024 May; 81(1):226. PubMed ID: 38775844
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway.
Rui X; Pan HF; Shao SL; Xu XM
BMC Complement Altern Med; 2017 Aug; 17(1):378. PubMed ID: 28764703
[TBL] [Abstract][Full Text] [Related]
7. Host CYP27A1 expression is essential for ovarian cancer progression.
He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER
Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer.
Liu W; Chakraborty B; Safi R; Kazmin D; Chang CY; McDonnell DP
Nat Commun; 2021 Aug; 12(1):5103. PubMed ID: 34429409
[TBL] [Abstract][Full Text] [Related]
9. Proscillaridin A induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate cancer cells.
He Y; Khan M; Yang J; Yao M; Yu S; Gao H
Int J Med Sci; 2018; 15(8):832-839. PubMed ID: 30008594
[TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxycholesterol suppress IFN-γ-induced inflammation in microglia by disrupting lipid raft formation and caveolin-mediated signaling endosomes.
Lee JH; Han JH; Woo JH; Jou I
Free Radic Biol Med; 2022 Feb; 179():252-265. PubMed ID: 34808332
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice.
Yu L; Xu L; Chu H; Peng J; Sacharidou A; Hsieh HH; Weinstock A; Khan S; Ma L; Durán JGB; McDonald J; Nelson ER; Park S; McDonnell DP; Moore KJ; Huang LJ; Fisher EA; Mineo C; Huang L; Shaul PW
Nat Commun; 2023 Jul; 14(1):4101. PubMed ID: 37491347
[TBL] [Abstract][Full Text] [Related]
12. STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.
Mohanty SK; Yagiz K; Pradhan D; Luthringer DJ; Amin MB; Alkan S; Cinar B
Oncotarget; 2017 Oct; 8(49):85997-86010. PubMed ID: 29156772
[TBL] [Abstract][Full Text] [Related]
13. Zhoushi Qi Ling decoction inhibits the progression of castration-resistant prostate cancer in vivo by regulating macrophage infiltration via IL6-STAT3 signaling.
Cao H; Wang D; Gao R; Chen L; Feng Y; Sun P
J Tradit Complement Med; 2024 Jan; 14(1):19-25. PubMed ID: 38223804
[TBL] [Abstract][Full Text] [Related]
14. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link.
Asghari A; Umetani M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650428
[TBL] [Abstract][Full Text] [Related]
15. SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells.
Gopalakrishnan S; Uma SK; Mohan G; Mohan A; Shanmugam G; Kumar VTV; J S; Chandrika SK; Vasudevan D; Nori SRC; Sathi SN; George S; Maliekal TT
Front Immunol; 2021; 12():740620. PubMed ID: 34867962
[TBL] [Abstract][Full Text] [Related]
16. Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway.
Zhang HX; Fan R; Chen QE; Zhang LJ; Hui Y; Xu P; Li SY; Chen GY; Chen WH; Shen DY
Heliyon; 2024 Mar; 10(5):e27217. PubMed ID: 38449612
[TBL] [Abstract][Full Text] [Related]
17. ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression.
Liu JP; Shen KY; Cheng WC; Chang WC; Hsieh CY; Lo CC; Kuo TT; Lin CC; Liu SJ; Huang WC; Sher YP
Am J Cancer Res; 2024; 14(4):1850-1865. PubMed ID: 38726266
[TBL] [Abstract][Full Text] [Related]
18. Targeting STAT3 Enzyme for Cancer Treatment.
Arun S; Patel PK; Lakhmanan K; Kalirajan R; Byran G
Mini Rev Med Chem; 2024 Jan; ():. PubMed ID: 38299278
[TBL] [Abstract][Full Text] [Related]
19. Correction for: miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis.
Li F; Li SS; Chen H; Zhao JZ; Hao J; Liu JM; Zu XG; Cui W
Aging (Albany NY); 2023 Oct; 15(20):11692-11693. PubMed ID: 37903553
[No Abstract] [Full Text] [Related]
20. ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer.
Liu ZH; Chen ML; Zhang Q; Zhang Y; An X; Luo YL; Liu XM; Liu SX; Liu Q; Yang T; Liu YM; Liu BL; Zhou AJ; Li MZ; Liu YJ; Liu ZX; Zhong Q
Int J Cancer; 2020 Jul; 147(2):505-518. PubMed ID: 32064600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
